Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
-
American Rare Earths Announces Zircon Co-Product Potential
-
Torr Metals Adds Multiple New Exploration Targets with 75% Expansion of Kolos Copper-Gold Project
-
REPEAT – Large Protests This Week Across Ontario in Response to Ford Government’s Health Care Privatization & Closures of Local Hospitals
-
The insurance industry has big ambitions for analytics but struggles to realize benefits as progress stalls
-
Grieg Seafood ASA: Notice of the Annual General Meeting 2024
-
Netcompany - Transactions in connection with share buyback programme
-
Tristan Schukraft’s Tryst Hospitality Acquires DS Tequila in Chicago’s Northalsted
-
Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference
-
Youth & Innovation Project : New report reveals insights on how Canadian youth are navigating a new employment reality
-
Heritage MD donates $500K to the MUHC Foundation to fund innovation at the McGill University Health Centre
-
Optiva a Finalist for Prestigious MVNOs World Congress Awards 2024
-
Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Cerence to Power Zeekr Multilingual AI Assistant
-
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
-
PingCAP Receives Customers’ Choice Distinction in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud Database Management Systems
-
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12
-
BioAtla to Participate in the Jefferies Global Healthcare Conference
-
AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan
-
Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) and Health Economics Outcomes Research Abstracts in NASH/MASH at the EASL Congress
-
Tachus Fiber Internet Leverages DZS Broadband Technology to Win Multiple National Awards for Broadband Service Excellence
-
Canary Medical’s Smart Spine Lumbar Cartridge Granted FDA “Breakthrough Device” Designation
-
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024
-
Accolade To Present at William Blair Growth Stock Conference
-
Danforth Advisors Acquires BW Health Group; Adds Commercial Readiness and Launch to Range of Integrated Services for Life Science Companies
-
Annika Colston Honored with the 2024 Women in Solar Energy Award by the American Solar Energy Society
-
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
-
Federal Budget Gives Canada's Health Minister The Power To Limit Contraception Access
-
Erasca to Present at Upcoming Investor Conferences in June
-
AYR Partners with Iconic Kowloon Restaurant to Launch Limited Edition LEVIA Kowloon Mai Tai THC Infused Seltzer
-
LifeMD Set to Join the Russell 3000 Index
-
Nusano Expands Executive Management to Support Q1 2025 Radioisotope Commercialization
-
Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment of ALS
-
Tevogen Bio Reports First Quarter 2024 Financial Results
-
Gift-Giving Made Easy: Momcozy Breast Pumps Join Babylist
-
Federal Budget Gives Canada's Health Minister The Power To Limit Contraception Access
-
The Oncology Institute to Participate at Upcoming Investor Conferences
-
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules
-
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12
-
Apollomics Announces Presentation at the 2024 BIO International Convention
-
Coda Octopus Group Elects Dr. Angus McFadzean to its Board of Directors
-
New Study Findings Show Statistically Significant Weight Loss for Medicare-Eligible Population in the Wondr Program
-
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
-
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June
-
Oruka Therapeutics to Present at the 2024 Jefferies Global Healthcare Conference
-
ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
-
Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting
-
Intercept Announces New Data to be Presented at the European Association for the Study of the Liver (EASL) Congress 2024
-
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers
-
Gentex Announces Second Quarter 2024 Cash Dividend
